Navigation Links
First Prostate Cancer Registry for Robotic Radiosurgery Patients Enrolls More than 500 Men

MIAMI, Sept. 30, 2011 /PRNewswire/ -- The CyberKnife Coalition announced today that more than 500 men treated with the CyberKnife Robotic Radiosurgery System® have now been enrolled in the first national patient registry designed specifically to track prostate cancer patients treated with stereotactic body radiation therapy. The multi-institutional Registry for Prostate Cancer Radiosurgery (RPCR), tracks clinical and functional outcomes of men with localized prostate cancer treated at academic and community based centers throughout the U.S.

Launched in July 2010, the RPCR is an independent IRB-approved observational trial registered with designed to collect information that will be useful in determining the role of radiosurgical treatment for patients with early-stage prostate cancer. In addition to tracking clinical data the registry also collects patient selection and quality of life information, which will be reported to the Centers for Medicare & Medicaid Services (CMS) and local Medicare contractors.

"We're excited to see such a positive response to the registry," said Mark Perman, M.D., CyberKnife Coalition board member, co-founder of the RPCR and member of South Florida Radiation Oncology. "The RPCR continues to grow rapidly and we are on track to have 20 centers participating by the end of this year.  I anticipate that the registry will become a mechanism for clinicians to measure the quality of the care they provide against a national benchmark of community-based and academic radiosurgery centers and will help fill in the evidence gaps pertaining to prostate radiation."  

Based on its strong belief in the need for the collection of clinical and patient-focused quality of life data for the therapies we offer our patients, the CyberKnife Coalition encourages participation of its membership to join the RPCR. The registry's ability to track real world data allows our members to make a meaningful contribution to the growing body of clinical research and helps to fill evidence gaps across the entire field of radiation.

"With more than 500 patients now enrolled, the RPCR has taken a significant step in building the most comprehensive data source on robotic radiosurgery for prostate cancer," said Linda Winger, president, the CyberKnife Coalition.

By participating in the registry, CyberKnife centers will be better equipped to help patients make the best decision for their individual circumstances, a view that is shared by the Agency for Healthcare Quality and Research who earlier this month published a patient guide entitled 'Knowing your Treatment Options', an overview of prostate cancer treatment options, that for the first time included SBRT as an treatment option for men with localized prostate cancer.

CyberKnife Coalition

Formed in May 2003 as an informal organization of CyberKnife facilities and formally incorporated in April 2005, the CyberKnife Coalition, Inc. (CKC) is a non-profit [501(c) 6] association of hospitals and freestanding centers across the United States committed to improving patient access to image-guided robotic stereotactic radiosurgery.  The CKC membership includes major academic institutions as well as community hospitals and clinics. All CKC member centers offer image-guided robotic stereotactic radiosurgery to treat malignant and benign tumors and other select disorders with high dose, precisely targeted radiation.

SOURCE CyberKnife Coalition
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 ... the addition of the "2016 Future Horizons ... Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, ... offering. --> ... comprehensive analysis of the Japanese therapeutic drug monitoring ...
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... -- ) has announced the ... Viscosity Drugs" report to their offering. ... of the "Self Administration of High Viscosity ... Research and Markets ( ) has ... of High Viscosity Drugs" report to their ...
Breaking Medicine Technology:
(Date:11/26/2015)... Omaha, NE (PRWEB) , ... November 26, 2015 , ... ... careers searched by healthcare professionals and offered by healthcare staffing agency Aureus Medical ... top during the month of October 2015 among those searching for healthcare jobs through ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel ... self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack comes with ... work with any font, giving users limitless opportunities to stylize and create designs ...
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast cancers found ... mammography, according to a study published online in the journal Radiology. Researchers said ... may necessitate a change in treatment. , Breast MRI is the most sensitive ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in the ... several models of traditional and far-infrared saunas. , For traditional saunas, Finnleo ... most traditional Finnish sauna wood, and Finnleo uses only European Grade A Nordic White ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
Breaking Medicine News(10 mins):